Janus Henderson Global Life Sciences Fund Class N Shares (JFNNX)
| Fund Assets | 5.40B |
| Expense Ratio | 0.68% |
| Min. Investment | $1,000,000 |
| Turnover | 30.00% |
| Dividend (ttm) | 3.77 |
| Dividend Yield | 4.63% |
| Dividend Growth | -7.44% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 5, 2025 |
| Previous Close | 82.87 |
| YTD Return | 2.52% |
| 1-Year Return | 33.81% |
| 5-Year Return | 51.55% |
| 52-Week Low | 64.76 |
| 52-Week High | 84.93 |
| Beta (5Y) | n/a |
| Holdings | 100 |
| Inception Date | Jan 26, 2018 |
About JFNNX
Janus Henderson Global Life Sciences Fund is an actively managed sector equity health fund launched by Janus Henderson in 2018. Its primary function is to provide long-term capital growth by investing in companies across the life sciences sector, including biotechnology, health care services, medical devices, and pharmaceuticals. The fund aims to outperform the MSCI World Health Care Index by at least 2% per annum over five years. It invests at least 80% of its assets in equities of companies addressing unmet medical needs or improving health care efficiencies. The fund is notable for its balanced portfolio approach and is managed by an experienced team specializing in health care science and business. This asset plays a significant role in the health care investment landscape, offering a diversified portfolio that aligns with the broader health care industry.
Performance
JFNNX had a total return of 33.81% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.10%.
Top 10 Holdings
41.35% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.86% |
| Johnson & Johnson | JNJ | 6.92% |
| AstraZeneca PLC | AZN | 4.39% |
| UnitedHealth Group Incorporated | UNH | 4.30% |
| AbbVie Inc. | ABBV | 3.92% |
| Revolution Medicines, Inc. | RVMD | 2.96% |
| Novartis AG ADR | NVSN.MX | 2.71% |
| argenx SE | ARGX | 2.51% |
| Thermo Fisher Scientific Inc. | TMO | 2.42% |
| Praxis Precision Medicines, Inc. | PRAX | 2.35% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 5, 2025 | $3.76513 | Dec 5, 2025 |
| Dec 6, 2024 | $4.06789 | Dec 6, 2024 |
| Dec 7, 2023 | $3.00343 | Dec 7, 2023 |
| Dec 20, 2022 | $0.27276 | Dec 20, 2022 |
| Dec 20, 2021 | $6.91402 | Dec 20, 2021 |
| Dec 17, 2020 | $5.65748 | Dec 17, 2020 |